HomeCompareIMRNW vs PM

IMRNW vs PM: Dividend Comparison 2026

IMRNW yields 2339.18% · PM yields 3.48%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IMRNW wins by $43075570633.30M in total portfolio value
10 years
IMRNW
IMRNW
● Live price
2339.18%
Share price
$0.09
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43075570633.35M
Annual income
$39,734,102,642,272,360.00
Full IMRNW calculator →
PM
Philip Morris International
● Live price
3.48%
Share price
$165.34
Annual div
$5.76
5Y div CAGR
17.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$2,492.02
Full PM calculator →

Portfolio growth — IMRNW vs PM

📍 IMRNW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIMRNWPM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IMRNW + PM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IMRNW pays
PM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IMRNW
Annual income on $10K today (after 15% tax)
$198,830.41/yr
After 10yr DRIP, annual income (after tax)
$33,773,987,245,931,504.00/yr
PM
Annual income on $10K today (after 15% tax)
$296.12/yr
After 10yr DRIP, annual income (after tax)
$2,118.22/yr
At 15% tax rate, IMRNW beats the other by $33,773,987,245,929,384.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IMRNW + PM for your $10,000?

IMRNW: 50%PM: 50%
100% PM50/50100% IMRNW
Portfolio after 10yr
$21537785316.70M
Annual income
$19,867,051,321,137,428.00/yr
Blended yield
92.24%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PM right now

IMRNW
No analyst data
PM
Analyst Ratings
17
Buy
7
Hold
1
Sell
Consensus: Buy
Price Target
$194.30
+17.5% upside vs current
Range: $180.00 — $205.00
Altman Z
4.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IMRNW buys
0
PM buys
0
No recent congressional trades found for IMRNW or PM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIMRNWPM
Forward yield2339.18%3.48%
Annual dividend / share$2.00$5.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17.2%
Portfolio after 10y$43075570633.35M$49.6K
Annual income after 10y$39,734,102,642,272,360.00$2,492.02
Total dividends collected$42841070616.16M$11.7K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: IMRNW vs PM ($10,000, DRIP)

YearIMRNW PortfolioIMRNW Income/yrPM PortfolioPM Income/yrGap
1← crossover$244,618$233,918.13$11,648$408.29+$233.0KIMRNW
2$5,609,462$5,347,721.02$13,589$495.90+$5.60MIMRNW
3$120,610,820$114,608,695.17$15,877$603.21+$120.59MIMRNW
4$2,432,079,455$2,303,025,877.36$18,580$734.88+$2432.06MIMRNW
5$46,004,003,878$43,401,678,861.20$21,781$896.75+$46003.98MIMRNW
6$816,480,868,143$767,256,583,993.93$25,578$1,096.12+$816480.84MIMRNW
7$13,600,083,122,647$12,726,448,593,733.79$30,092$1,342.17+$13600083.09MIMRNW
8$212,667,837,578,363$198,115,748,637,130.90$35,470$1,646.46+$212667837.54MIMRNW
9$3,122,867,281,384,664$2,895,312,695,175,815.50$41,892$2,023.58+$3122867281.34MIMRNW
10$43,075,570,633,353,950$39,734,102,642,272,360.00$49,578$2,492.02+$43075570633.30MIMRNW

IMRNW vs PM: Complete Analysis 2026

IMRNWStock

Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, Israel, Canada, the United States, and internationally. The company operates through two segments, Research and Development, and Hyperimmune Products. It offers Travelan, an over-the-counter medicine to reduce the risk of travelers’ diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for support digestive health and gastrointestinal tract protection; and Protectyn, an immune supplement to help maintain a healthy digestive function and liver. The company is also developing Travelan (IMM-124E) to reduce the risk of contracting travelers’ diarrhea in the United States, and Travelers’ Diarrhea; and IMM-529, for treating patients suffering from recurring clostridium difficile infection. It has a research agreement with Naval Medical Research Center to develop and clinically evaluate a therapeutic targeting Campylobacter and enterotoxigenic Escherichia coli infections; and a collaboration agreement with the Walter Reed Army Institute of Research to develop an oral therapeutic for shigellosis. Immuron Limited was incorporated in 1994 and is headquartered in Carlton, Australia.

Full IMRNW Calculator →

PMConsumer Staples

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

Full PM Calculator →
📬

Get this IMRNW vs PM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IMRNW vs SCHDIMRNW vs JEPIIMRNW vs OIMRNW vs KOIMRNW vs MAINIMRNW vs MOIMRNW vs BTIIMRNW vs PEP

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.